We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

Geistlich History

2019Geistlich welcomes his 12th daughter: the expanded presence in Asia leads to the foundation of Geistlich Pharma Japan K.K.
2016Geistlich Pharma India Pvt. Ltd., based in New Delhi, is a member of the Swiss parent company.
2014Geistlich Pharma New Zealand and Australia Pty Ltd. have been established.
2012The eighth affiliate Geistlich Pharma North America starts operations and is marketing biomaterials for bone regeneration in the USA and Canada.
2011Geistlich Pharma expands its presence in Asia by setting up an affiliate in South Korea in addition to the affiliate set up in China in 2008.
2010Geistlich Pharma sets up the affiliate Geistlich Pharma do Brasil based in Sao Paolo. In future Geistlich biomaterials will be available directly on the largest South American market.
2008Foundation of the French affiliate Geistlich Pharma France SA. in Roissy-en-France near Paris. The Geistlich Pharma Representative office in Peking becomes the Chinese affiliate Geistlich Trading (Beijing) Co., Ltd.
2006The industrial bone processing is discontinued.
2005The Geistlich Pharma Representative Office is established in Peking with the objective to provide scientific support to the regenerative medicine and to further promote our technologies and products in China.
2003 The subsidiary Geistlich Biomaterials Italia is founded in Thiene, Italy.
2002Production of gelatine is given up. The collagen foil activities are sold in 2005.
1999The Geistlich company is converted into a holding company. The operational activities are assembled in newly formed subsidaries: Geistlich Pharma AG (biomaterials, pharmaceuticals), Geistlich Ligamenta AG (adhesives), Geistlich Alimenta AG (collagen foils), Geistlich Agrasana AG (fats and fertilizers), and Geistlich Immobilia AG (real estate).
1996Foundation of the German subsidiary Geistlich Biomaterials Vertriebsgesellschaft mbH in Baden-Baden
1995The Geistlich company incorporates a quality system, that is certified according to ISO 9001:2000.Geistlich Pharma is additionally certified according to ISO 13485:2003, RL 93/42 EWG and CMDCAS and has implemented the requirements of 21 CFR Part 820.
1986Geistlich Bio-Oss® is the first natural bone substitution material produced by the Biomaterials Division. Other biomaterials are realised outgoing by this innovation for the dental medicine and orthopedics.
1960The subsidiary, Geistlich Sons Ltd. in Chester, Great Britain is founded. Since then, further collaborations have continued to be made throughout the world.
1951Acquisition of the majority of the shares of Delta Zofingen AG
1950GEWO GmbH subsidiary is founded in Baden-Baden, Germany.
1909the sons of Eduard Geistlich transform the company into a shareholder company. The company developed further and took up production of pharmaceutical products in 1943.
1869more space was needed so the company moved to Schlieren. Here the company started it's considerable growth. In 1899 Eduard Geistlich, Heinrich's son, acquired a factory in Wolhusen/ Lucerne which was developed to facilitate their growing activities.
1851The "glue factory" was founded in Zurich by Heinrich Geistlich.